Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Better Therapeutics, Inc. (BTTX)
OTHER OTC:BTTX
Holding BTTX?
Track your performance easily
BTTX Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.24
Previous CloseN/A
Volume65.57K
Average Volume (3M)42.40K
Market Cap
$5.43K
Enterprise ValueN/A
Total Cash (Recent Filing)$757.00K
Total Debt (Recent Filing)$5.00M
Price to Earnings (P/E)―
Beta225.26
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.16
Shares Outstanding54,352,497
10 Day Avg. Volume2
30 Day Avg. Volume42,396
Standard Deviation0.36
R-Squared0.06
Alpha-0.12
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Better Therapeutics, Inc. News
PremiumCompany Announcements
Better Therapeutics Overhaul and Nasdaq Delisting
PremiumCompany Announcements
Better Therapeutics Issues Investor Presentation with Cautions
PremiumCompany Announcements
Better Therapeutics CEO Discusses Future on Bloomberg TVOptions Prices
Currently, No data available
---
Ownership Overview
35.69% Insiders
0.13% Other Institutional Investors
64.18% Public Companies and
Individual Investors
BTTX FAQ
What was Better Therapeutics, Inc.’s price range in the past 12 months?
Better Therapeutics, Inc. lowest stock price was <$0.01 and its highest was $0.24 in the past 12 months.
What is Better Therapeutics, Inc.’s market cap?
Better Therapeutics, Inc.’s market cap is $5.43K.
When is Better Therapeutics, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Better Therapeutics, Inc.’s earnings last quarter?
Currently, no data Available
Is Better Therapeutics, Inc. overvalued?
According to Wall Street analysts Better Therapeutics, Inc.’s price is currently Overvalued.
Does Better Therapeutics, Inc. pay dividends?
Better Therapeutics, Inc. does not currently pay dividends.
What is Better Therapeutics, Inc.’s EPS estimate?
Better Therapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Better Therapeutics, Inc. have?
Better Therapeutics, Inc. has 54,352,497 shares outstanding.
What happened to Better Therapeutics, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Better Therapeutics, Inc.?
Currently, no hedge funds are holding shares in BTTX
---
Company Description
Better Therapeutics, Inc.
Mountain Crest Acquisition Corp II is a blank check company.
---
BTTX Earnings Call
Q3 2023
0:00 / 0:00
---
Aldeyra Therapeutics
―
Bioxcel Therapeutics
―
Krystal Biotech
―
Anavex Life Sciences
―
Axsome Therapeutics
―
SELLAS Life Sciences Group
―
---